# Clinical trials recruiting in Virginia: 1,973 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,973 trials recruiting or not yet recruiting with a site in Virginia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Virginia: 1,973 rows for $98.65, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 36 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/virginia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,973
- Recruiting or not yet: 1,973
- Read on: November 19, 2026

## Trials

The 25 newest of 1,973, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946302 | A Phase I Dose-Escalation Study of CUG279 in Participants With Select Advanced or Metastatic Solid Tumors | Cugene Inc. | Phase 1 | Recruiting | Advanced Solid Tumor (Phase 1) | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946302) |
| November 17, 2026 | NCT07942012 | PHORA-USE Registry (PHORAR) | Sentara Norfolk General Hospital | Observational | Not yet recruiting | Pulmonary Arterial Hypertension | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942012) |
| November 16, 2026 | NCT07937410 | Chronic Subdural Hematoma Recurrence | Carilion Clinic | Phase 1/2 | Recruiting | Chronic Subdural Hematoma, Recurrent | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937410) |
| November 13, 2026 | NCT07935317 | A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast Cancer | Eli Lilly and Company | Phase 2 | Not yet recruiting | Breast Neoplasms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935317) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07930325 | The Impact of Peanuts on Brain Function in Young Adults | Sponsor not shown (see the record) | Not applicable | Recruiting | Stress | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930325) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07923045 | A Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of MR-146 in Subjects With Stage I and Stage II Neurotrophic Keratopathy | Viatris Inc. | Phase 1/2 | Recruiting | Neurotrophic Keratopathy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923045) |
| November 6, 2026 | NCT07923032 | Low-Intensity Focused Ultrasound for Gambling Disorder | University of Virginia | Not applicable | Not yet recruiting | Gambling Disorder, Gambling Addiction, Gambling Problem, Gambling | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923032) |
| November 5, 2026 | NCT07919847 | Universal Screening for Blunt Cerebrovascular Injury | Inova Health Care Services | Not applicable | Not yet recruiting | Cerebrovascular Trauma | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919847) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07913074 | A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With... | Tavo Biotherapeutics | Phase 2 | Recruiting | Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913074) |
| November 3, 2026 | NCT07912593 | A KRAS Inhibitor in Participants With Advanced Solid Tumors | Ensem Therapeutics | Phase 1/2 | Recruiting | Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer... | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912593) |
| November 3, 2026 | NCT07912502 | Feasibility of a Mindfulness and Physical Activity Promotion Intervention After Anterior Cruciate Ligament Reconstruction | University of Virginia | Not applicable | Not yet recruiting | Anterior Cruciate Ligament (ACL) Reconstruction | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912502) |
| November 2, 2026 | NCT07909356 | A Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha... | Medicovestor, Inc | Phase 1 | Not yet recruiting | Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumor Cancer, Metastatic Pancreatic Cancer, Metastatic Solid... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909356) |
| November 2, 2026 | NCT07909031 | CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Crescent Biopharma, Inc. | Phase 1/2 | Recruiting | Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)... | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909031) |
| October 29, 2026 | NCT07905001 | A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer | Prelude Therapeutics Incorporated | Phase 1 | Recruiting | Breast Cancer, Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, HR-positive Breast Cancer... | 242 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905001) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 27, 2026 | NCT07897370 | Cardiac Arrest - Ultrasound Detection of Occult Perfusion | University of Massachusetts, Worcester | Observational | Recruiting | Cardiac Arrest, Out-Of-Hospital, Hypotension | 1,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897370) |
| October 26, 2026 | NCT07895017 | Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell Cytopenias | University of Virginia | Phase 2 | Not yet recruiting | Thrombocytopenia | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895017) |
| October 23, 2026 | NCT07891637 | Effects of a Novel Perturbation Balance Training Program on Laboratory and Real-World Trip-Induced Losses of Balance and Falls Among... | Virginia Polytechnic Institute and State University | Not applicable | Not yet recruiting | Accidental Fall | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891637) |
| October 23, 2026 | NCT07891039 | ESP Blocks in Breast Free Flaps | Carilion Clinic | Phase 1 | Recruiting | Breast Reconstruction, Free Flap Reconstruction | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891039) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Virginia | Charlottesville | 185 |
| Virginia Commonwealth University | Richmond | 152 |
| VCU Massey Comprehensive Cancer Center | Richmond | 125 |
| University of Virginia Cancer Center | Charlottesville | 91 |
| Virginia Cancer Specialists | Fairfax | 89 |
| VCU Massey Cancer Center at Stony Point | Richmond | 56 |
| Inova Schar Cancer Institute | Fairfax | 55 |
| Inova Fairfax Hospital | Falls Church | 54 |
| University of Virginia Health System | Charlottesville | 51 |
| Virginia Oncology Associates | Chesapeake | 44 |
| Children's Hospital of The King's Daughters | Norfolk | 34 |
| Sentara Norfolk General Hospital | Norfolk | 34 |
| VCU Community Memorial Health Center | South Hill | 32 |
| Bon Secours Saint Francis Medical Center | Midlothian | 31 |
| Virginia Cancer Institute | Richmond | 30 |
| Bon Secours Memorial Regional Medical Center | Mechanicsville | 27 |
| Bon Secours Saint Mary's Hospital | Richmond | 27 |
| NEXT Oncology Virginia | Fairfax | 27 |
| Virginia Cancer Specialists, PC | Fairfax | 25 |
| Carilion Clinic | Roanoke | 24 |
| University of Virginia Medical Center | Charlottesville | 22 |
| Bon Secours Cancer Institute at Reynolds Crossing | Richmond | 21 |
| Carilion Roanoke Memorial Hospital | Roanoke | 18 |
| Blue Ridge Cancer Care | Blacksburg | 17 |
| Carilion Children's | Roanoke | 15 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 16 |
| Phase 1 | 208 |
| Phase 1/2 | 202 |
| Phase 2 | 337 |
| Phase 2/3 | 67 |
| Phase 3 | 553 |
| Phase 4 | 54 |
| Not applicable | 316 |
| Observational | 220 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 159 |
| Breast Neoplasms | 96 |
| Neoplasms | 88 |
| Colorectal Neoplasms | 82 |
| Neoplasm Metastasis | 72 |
| Lung Neoplasms | 65 |
| Ovarian Neoplasms | 62 |
| Endometrial Neoplasms | 61 |
| Prostatic Neoplasms | 57 |
| Squamous Cell Carcinoma of Head and Neck | 51 |
| Obesity | 50 |
| Pancreatic Neoplasms | 49 |
| Heart Failure | 40 |
| Overweight | 37 |
| Melanoma | 37 |
| Diabetes Mellitus, Type 2 | 34 |
| Triple Negative Breast Neoplasms | 32 |
| Stomach Neoplasms | 32 |
| Small Cell Lung Carcinoma | 31 |
| Recurrence | 28 |
| Urinary Bladder Neoplasms | 27 |
| Cardiovascular Diseases | 26 |
| Colonic Neoplasms | 26 |
| Carcinoma, Transitional Cell | 26 |
| Multiple Myeloma | 25 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Virginia | 95 |
| Virginia Commonwealth University | 75 |
| National Cancer Institute (NCI) | 67 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 63 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 44 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 44 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 36 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 33 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 23 |
| SWOG Cancer Research Network | 23 |
| Alliance for Clinical Trials in Oncology | 23 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 23 |
| Children's Oncology Group | 21 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 20 |
| Virginia Polytechnic Institute and State University | 20 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 19 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 19 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 19 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 18 |
| Inova Health Care Services | 18 |
| NRG Oncology | 17 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 17 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 14 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 14 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 13 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Virginia

- [Lawn care companies in Virginia, United States](https://specstream.ai/data/businesses/lawn-care-companies/virginia-united-states)
- [Surgery practices in Virginia, United States](https://specstream.ai/data/businesses/surgery-practices/virginia-united-states)
- [Colleges and universities in Virginia, United States](https://specstream.ai/data/businesses/colleges-and-universities/virginia-united-states)
- [Junk removal companies in Virginia, United States](https://specstream.ai/data/businesses/junk-removal-companies/virginia-united-states)
- [Specialty schools in Virginia, United States](https://specstream.ai/data/businesses/specialty-schools/virginia-united-states)
- [Chicken restaurants in Virginia, United States](https://specstream.ai/data/businesses/chicken-restaurants/virginia-united-states)
